Veracyte director Jens Holstein disposes of USD 204,747 common shares

• Veracyte director Jens Holstein sold 5,000 common shares on Sept. 14, 2026 at a weighted average price of $40.95.
• Holdings fell to 27,471 shares following the sale.
• Transaction was executed under a Rule 10b5-1 trading plan adopted on June 12, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veracyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001819880-26-000004), on September 16, 2026, and is solely responsible for the information contained therein.